ClinicalTrials.Veeva

Menu

Respiratory Mechanics and Metabolic Changes During Low Pressure Laparoscopic Cholecystectomy

A

Assiut University

Status and phase

Completed
Phase 2

Conditions

Laparoscopic Cholecystectomy

Treatments

Drug: Rocuronium

Study type

Interventional

Funder types

Other

Identifiers

NCT02469831
low pressure lap chole.

Details and patient eligibility

About

The investigators aim to investigate the differences between deep continuous muscle relaxation and moderate blockade during low-pressure (8 mmHg) laparoscopic cholecystectomy in respect to metabolic changes and respiratory mechanics.

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • more than 18 years
  • undergoing elective laparoscopic cholecystectomy

Exclusion criteria

  • previous surgeries,
  • a history of venous or arterial diseases,
  • BMI (≥30 kg/m2),
  • Allergy to rocuronium.
  • Significant liver dysfunction.
  • Significant renal dysfunction (S-creatinine > 200 umol/l).
  • Neuromuscular disease that might impair neuromuscular blockade
  • Pregnant or breastfeeding.
  • Indication for rapid sequence induction.
  • Inability to informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

group D
Active Comparator group
Description:
deep neuromuscular block by rocuronium defined :post tetanic (PTC) \>1 but no response to a train of four (TOF) stimulation.
Treatment:
Drug: Rocuronium
group I
Active Comparator group
Description:
intermediate neuromuscular block by rocuronium defined as TOF count of 1-3.
Treatment:
Drug: Rocuronium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems